The study treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works by blocking a certain hormone called aldosterone that causes injury and inflammation in the heart and kidney which is known to play a role in CKD. In this study, the researchers want to learn if finerenone works the same way in kidney transplant recipients. Some subjects will receive the study drug and some will receive a placebo.

Do you have pancreatic ductal adenocarcinoma that has come back after receiving standard therapy? If so, you may be able to participate in this gene therapy research study to learn more about using you own modified immune cells as possible treatment.

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders.

Have you been diagnosed with a B cell disease that has returned after your previous treatment or is not responding to your current treatment? If so, you might be able to take part in a study to see if a new treatment is safe and can help treat people with B-cell diseases.

You will be informed of the purpose of this study at the end of the survey.

The purpose of this study is to identify why households waste food. Using these causes of household food waste, we will work with participants to develop a comprehensive packet of tools that can be implemented in their daily lives to prevent food waste.

Do you have cervical cancer and are confused about health insurance or paying for your healthcare? We want to hear your thoughts on what might make it easier to navigate the financial side of cancer treatment. Your participation will help us to build a program to help cervical cancer patients like you. Compensation provided.

Do you have Non-Small Cell Lung Cancer? Have you previously been treated with Osimertinib? If so, you may be eligible for a trial comparing osimertinib in combination with other medications to treat your lung cancer. Please reach out if you're interested!

Have you been diagnosed with early stage triple negative breast cancer? We are asking you to take part in this research study because you have been diagnosed with triple-negative breast cancer (TNBC) and have recently completed preoperative chemotherapy in combination with pembrolizumab, followed by breast surgery. The chemotherapy plus pembrolizumab produced a pathologic complete response (pCR), meaning that no remaining cancer was found during your breast surgery.

In this project, we want to learn more about transgender and nonbinary individuals' sexual satisfaction. Sexual satisfaction is a prominent indicator of an individual's well-being and satisfaction with life. Current research focuses mainly on cisgender heterosexual populations. By focusing on people who identify under the nonbinary umbrella, in addition to binary-identifying trans people, we hope to examine how gender, the sociopolitical world, and a person's sexual satisfaction all intersect.